Medicare Part D Benefit Redesign
Quantitatively and continuously demonstrating the impact of Part D benefit redesign proposals for specific products, portfolios, therapeutic areas, and industry-wide, using ADVI’s access to Part D claims.
Quantitatively and continuously demonstrating the impact of Part D benefit redesign proposals for specific products, portfolios, therapeutic areas, and industry-wide, using ADVI’s access to Part D claims.
CEO insights
Related articles
Real analysis from people who’ve been there
Evaluation of Biosimilar Utilization by Hospital Types
Worked with a pharmaceutical trade organization to identify biosimilars of interest.
Advocacy Coalition for Uptake of Comprehensive Genomic Profiling
Worked with a diverse group of industry stakeholders including diagnostics manufacturers, laboratories, academic institutions, and disease-specific advocacy groups to redefine comprehensive genomic profiling through the creation of a “new narrative”.
Reach out
Own your edge
We don’t just guide the market. We shape it. Map your market access moves with #ADVIIntelligence. Proven advantage. Unmatched partnership.